Caterina MARCHIO'

Associate Professor of Pathology

University of Turin

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Caterina Marchio' is an Associate Professor of Pathology at the University of Turin, Italy. Her research areas include breast carcinoma, metastatic colorectal cancer, malignant pleural mesothelioma, and the analysis of tumor-infiltrating lymphocytes in breast cancer. She has contributed significantly to the understanding of tumor genetics and treatment responses through her recent publications.

Articles (12)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (27)

Sharon Glynn

Associate Professor in Pathology

University of Galway

IRELAND

Caterina MARCHIO'

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Human sporadic breast carcinoma histotypes driven by the Human Betaretrovirus homologous to Mouse Mammary Tumor Virus

Quantifying mRNA in Highly Degraded Fixed Tissues by Nanostring Technology: A Comparative Study

ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations

Synthetic Lethal Interaction with BCL-XL Blockade Deepens Response to Cetuximab in Patient-Derived Models of Metastatic Colorectal Cancer

The Genes–Stemness–Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints

Tissue Fixation with a Formic Acid-Deprived Formalin Better Preserves DNA Integrity over Time

Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST

The Tumor-Specific Expression of L1 Retrotransposons Independently Correlates with Time to Relapse in Hormone-Negative Breast Cancer Patients

Definition of High-Risk Early Hormone-Positive HER2&minus;Negative Breast Cancer: A Consensus Review

HER2-Low Breast Cancer: Where Are We?

Unusual Patterns of HER2 Expression in Breast Cancer: Insights and Perspectives

Molecular Characterization of Prostate Cancers in the Precision Medicine Era

Collaborators (27)

Sharon Glynn

Valeria Leuci

Laura Annaratone

Vurchio Valentina

Livio Trusolino

ELIA BARI

Irene Catalano

Anikó Kovács

Francesco Sassi

Enrico Berrino

Evandro de Azambuja

Peter Regitnig

Serena Bonin

Tiziana Venesio

Elena Grassi

Paolo Marchetti

sara erika bellomo

Giulia M. Stella

paolo fattorini

Umberto Miglio

soldano ferrone

Silvia GIORDANO

Maria P. Foschini

Ilaria Ferrarotti

Dario Sangiolo

Anna Sapino

GIULIA MESIANO

Make your next move.

Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review